Skip to main content
Clinical Trials/NL-OMON44301
NL-OMON44301
Completed
Not Applicable

ovel mass spectrometric monitoring (steroid metabolomics) to detect treatment success and chronic over- or under-treatment in children with CAH (CAH metabolomics). - Novel CAH monitoring tools

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • The subjects must have a genetically confirmed diagnosis of classical CAH (salt\-losing or simple virilising) and
  • \- group 1: being pre\-pubertal and Tanner stage 1
  • \- group 2: being late\-pubertal and Tanner stage 3 plus or post\-menarche
  • The subjects must personally provide, or have a legal guardian provide, written informed consent to participate in the trial, according to local regulations.

Exclusion Criteria

  • \- Intercurrent illnesses at or within one week before visit.
  • \- Poor understanding of language by subjects and/or legal guardians, leading to insufficient ability to understand the written study information form.

Outcomes

Primary Outcomes

Not specified

Similar Trials